Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov;15(11):829-38.
doi: 10.1111/hpb.12038. Epub 2013 Jan 10.

Review of the investigation and surgical management of resectable ampullary adenocarcinoma

James Askew  1 , Saxon Connor  1
Affiliations

Review of the investigation and surgical management of resectable ampullary adenocarcinoma

James Askew et al. HPB (Oxford). 2013 Nov.

Abstract

Background: Ampullary adenocarcinoma is considered to have a better prognosis than either pancreatic or bile duct adenocarcinoma. Pancreaticoduodenectomy is associated with significant mortality and morbidity. Some recent publications have advocated the use of endoscopic papillectomy for the treatment of early ampullary adenocarcinoma. This article reviews investigations and surgical treatment options of ampullary tumours.

Methods: A systematic review of English-language articles was carried out using an electronic search of the Ovid MEDLINE (from 1996 onwards), PubMed and Cochrane Database of Systematic Reviews databases to identify studies related to the investigation and management of ampullary tumours.

Results: Distinguishing between ampullary adenoma and adenocarcinoma is challenging given the inaccuracy of endoscopic biopsy, for which high false negative rates of 25-50% have been reported. Endoscopic ultrasound is the most accurate method for local staging of ampullary lesions, but distinguishing between T1 and T2 adenocarcinomas is difficult. Lymph node metastasis occurs early in the disease process; it is lowest for T1 tumours, but the risk is still high at 8-45%. Case reports of successful endoscopic resection and transduodenal ampullectomy of T1 adenocarcinomas have been published, but their duration of follow-up is limited.

Conclusions: Optimal staging should be used to distinguish between ampullary adenoma and adenocarcinoma. Pancreaticoduodenectomy remains the treatment of choice for all ampullary adenocarcinomas.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Modified PRISMA (preferred reporting items for systematic reviews and meta-analyses) flow diagram showing study methodology
See this image and copyright information in PMC

References

    1. Albores-Saavedra J, Schwartz AM, Batich K, Henson DE. Cancers of the ampulla of Vater: demographics, morphology, and survival based on 5625 cases from the SEER programme. J Surg Oncol. 2009;100:598–605. - PubMed
    1. O'Connell JB, Maggard MA, Manunga J, Jr, Tomlinson JS, Reber HA, Ko CY, et al. Survival after resection of ampullary carcinoma: a national population-based study. Ann Surg Oncol. 2008;15:1820–1827. - PubMed
    1. Fischer H-P, Zhou H. Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg. 2004;11:301–309. - PubMed
    1. Reummele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, et al. Histopathologic features and microsatellite instability of cancers of the papilla of Vater and their precursor lesions. Am J Surg Pathol. 2009;33:691–704. - PubMed
    1. Wittekind C, Tannapfel A. Adenoma of the papilla and ampulla – premalignant lesions? Langenbecks Arch Surg. 2001;20:172–175. - PubMed

Publication types